HPV Legislation Doesn't Impact Teen Sexual Behaviors
WEDNESDAY, Aug. 15, 2018 -- Implementation of state legislation relating to human papillomavirus (HPV) vaccination is not associated with changes in adolescent sexual behaviors, according to a study published online Aug. 13 in Pediatrics. Erin E.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 15, 2018 Category: Pharmaceuticals Source Type: news

Vaginal Rejuvenation Manufacturers Land in Hot Water with FDA
 Back in February, MD+DI got the low down from an obstetrics and gynecologist specialist in Lubbock, TX on a new vaginal rejuvenation device that her patients have been raving about.  Now it seems the manufacturer of that particular device, along with other companies selling laser- or energy-based devices for vaginal rejuvenation failed to get FDA's blessing. "We've recently become aware of a growing number of manufacturers marketing 'vaginal rejuvenation' devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence, or...
Source: MDDI - August 14, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: Regulatory and Compliance Source Type: news

Cetuximab+RT found to be inferior to standard treatment in HPV+ oropharyngeal cancer
(NIH/National Cancer Institute) An interim analysis of data from a randomized clinical trial of patients with human papillomavirus (HPV)-positive oropharyngeal cancer found that treatment with radiation therapy and cetuximab is associated with worse overall and progression-free survival compared to the current standard treatment with radiation and cisplatin. The trial was designed to see if cetuximab with radiation would be less toxic than cisplatin with radiation without compromising survival for patients with the disease. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 14, 2018 Category: Cancer & Oncology Source Type: news

State HPV vaccine laws do not appear to influence teen sex
(Reuters Health) - State laws designed to increase teen vaccination against the cancer-causing human papillomavirus (HPV) don't appear to influence adolescents' choices about whether to become sexually active or use condoms, a U.S. study suggests. (Source: Reuters: Health)
Source: Reuters: Health - August 13, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Promoting HPV Vaccine Doesn't Prompt Risky Sex by Teens: Study
MONDAY, Aug. 13, 2018 -- Controversial state laws that promote vaccinating kids against the human papillomavirus (HPV) do not increase the likelihood that teens will engage in risky sexual behavior, a new study contends. " Parents and caregivers, as... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2018 Category: General Medicine Source Type: news

Catch-Up HPV Shots Work for Teen Girls
WEDNESDAY, Aug. 8, 2018 -- Human papillomavirus (HPV) vaccinations are effective for teen girls who didn't get the recommended shots when they were 11 or 12, researchers report. The Kaiser Permanente study of more than 25,000 women aged 26 and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news

The Lancet Child & Adolescent Health: Catch-up HPV vaccine effective for women aged up to 20 years, US study suggests
(The Lancet) US study confirms effectiveness of quadrivalent human papillomavirus (HPV) vaccine in women aged up to 20 years who receive all three doses, but more research is needed in women aged 21-26 years. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - August 7, 2018 Category: Infectious Diseases Source Type: news

Plymouth Meeting-based Inovio teams up with AIDS Malignancy Consortium for immunotherapy study
Inovio Pharmaceuticals, Inc. has entered into a partnership with the AIDS Malignancy Consortium to evaluate VGX-3100 as a potential therapy for HIV-positive adult men and women. The Plymouth Meeting, Pa., biopharmaceutical company is developing VGX-3100, an immunotherapy designed to boost the ability of person's immune system to fight diseases, as a treatment for human papillomavirus (HPV)-associated precancerous conditions. Under the terms of the partnership, the consor tium will fund a mid-stage… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 6, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

Roche is on the “SurePath” for Cervical Cancer Screening with Approval
Roche has won a monumental approval from FDA that stands to enhance its cervical cancer detection offerings. The Basel, Switzerland-based company has received a nod for its cobas Human Papillomavirus (HPV) Test as a first-line screening test for cervical cancer in women 25 and older using cervical specimens collected in SurePath preservative fluid. "Before today, laboratories did not have an FDA-approved HPV test available that could cover all of the HPV screening options supported in professional guidelines and be used with both of the primary Pap test collection media," Ann Costello, Head of Roche Tissue Diagno...
Source: MDDI - August 3, 2018 Category: Medical Devices Authors: Omar Ford Tags: IVD Source Type: news

FDA wages war on vaginal rejuvenation
Years ago, the agency approved the use of laser-based and energy-powered devices to remove genital warts. But on Monday the FDA said the devices are being used for 'vaginal rejuvenation'. (Source: the Mail online | Health)
Source: the Mail online | Health - July 30, 2018 Category: Consumer Health News Source Type: news

No Higher Risk of Autoimmune Disorders After HPV4 Vaccination
MONDAY, July 30, 2018 -- Following quadrivalent human papillomavirus (HPV4) vaccination, girls age 12 to 17 years do not have increased risk of autoimmune disorders, according to a study published recently in CMAJ, the journal of the Canadian... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 30, 2018 Category: Pharmaceuticals Source Type: news

Second Primary Malignancy Risk Doubled After Head and Neck Cancer Second Primary Malignancy Risk Doubled After Head and Neck Cancer
The risk of second primary malignant neoplasm (SPMN) doubles after a first head and neck squamous cell carcinoma (HNSCC), especially when the site of the first cancer is not typically associated with malignancies due to human papillomavirus (HPV), according to a retrospective study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 27, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Medical News Today: What are the early signs of oral cancer?
Oral cancer can affect any part of the mouth, including the front of the tongue, the lips, the gums, or inside the cheeks. Symptoms include ulcers that do not heal and pain in the affected area. Causes include the presence of the human papillomavirus (HPV). Learn more about the warning signs of oral cancer here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 25, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

The HPV vaccine will be given to boys as well as girls in England
A vaccine against the human papillomavirus, or HPV, will be given to boys in England for the first time, the UK government announced on Tuesday. (Source: CNN.com - Health)
Source: CNN.com - Health - July 24, 2018 Category: Consumer Health News Source Type: news

Teenage boys in England will be vaccinated against HPV
The NHS will embark on a £20 million a year programme to vaccinate all 12 and 13 year old males against the sexually transmitted human papillomavirus, which causes oral cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - July 24, 2018 Category: Consumer Health News Source Type: news

HPV Vaccine Eliminates Advanced Skin Cancer in 97-Year-Old
TUESDAY, July 24, 2018 -- The 9-valent human papillomavirus (HPV) vaccine could be a therapeutic option for patients with cutaneous squamous cell carcinoma when surgical management is not an option, according to a case report published online July 3... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Teenage boys will be vaccinated against HPV which causes the deaths of hundreds of men every year
In a landmark victory for The Mail on Sunday, the NHS will embark on a £20 million annual programme to inoculate all 12- and 13-year-olds against the sexually transmitted human papillomavirus. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2018 Category: Consumer Health News Source Type: news

Government advisors back extending HPV vaccine to boys
School age boys in the UK should be offered vaccination against the cancer causing human papillomavirus (HPV), according to government advisors. (Source: Nursing Times)
Source: Nursing Times - July 19, 2018 Category: Nursing Source Type: news

Quadrivalent HPV Vaccine Not Tied to Spontaneous Abortion
MONDAY, July 16, 2018 -- The quadrivalent human papillomavirus vaccine (4vHPV) is not associated with an increased risk of spontaneous abortion when inadvertently given before or during pregnancy, according to a study published in the July issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 16, 2018 Category: Pharmaceuticals Source Type: news

Cervarix (Human Papillomavirus Bivalent Vaccine) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Massive failure in cervical cancer screening prompts Ireland to overhaul testing
Irish health authorities will start screening women for cervical cancer with a test for human papillomavirus (HPV) — something a Canadian study recently recommended. (Source: CBC | Health)
Source: CBC | Health - July 9, 2018 Category: Consumer Health News Tags: News/Health Source Type: news

What is the Interval For Non-simultaneous Administration of Live Virus Vaccines?
Discussion Vaccines are a mainstay of infectious disease prevention and health promotion. Infants, children and adults benefit from vaccines the most when they are given on the recommended schedules. However there are times when this is not possible as children come to the physician a little early, or a little late, or had unavailable records and so received addition vaccine, etc. There are many questions that arise because of these timing issues such as the one above. Standard vaccine schedules can be reviewed here. Commonly administered vaccines includes: Live-attenuated vaccines Cholera Measles, mumps, rubella (MMR ...
Source: PediatricEducation.org - July 9, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Medical News Today: What does HPV look like in your mouth?
Human papillomavirus (HPV) can affect the mouth, as well as other places. Symptoms include small, hard bumps that can be slow-growing. Not using proper protection during oral sex is one of the causes of HPV in the mouth. There is no cure, but a vaccine can lower the risk of developing the virus. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 4, 2018 Category: Consumer Health News Tags: Sexual Health / STDs Source Type: news

HPV test is better than Pap smear at detecting precancerous cervical changes, study says
A test for HPV detects precancerous changes of the cervix earlier and more accurately than the Pap smear, according to a large clinical trial published Tuesday.The randomized, controlled study — the kind of trial considered the "gold standard" of research — showed that the human papillomavirus... (Source: Los Angeles Times - Science)
Source: Los Angeles Times - Science - July 3, 2018 Category: Science Authors: Laurie McGinley Source Type: news

HPV Cervical CA Screening Cuts Odds of Later CIN3 & #43; Diagnosis
TUESDAY, July 3, 2018 -- The use of primary human papillomavirus (HPV) testing versus cytology results in reduced likelihood of cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+) at 48 months, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 3, 2018 Category: Pharmaceuticals Source Type: news

HPV test tops Pap smear in cancer screening study
A new study finds that testing for the human papillomavirus or HPV was linked with significantly fewer cases of precancer in a 48-month period -- meaning the precancer was detected earlier -- compared with using pap smear testing. (Source: CNN.com - Health)
Source: CNN.com - Health - July 3, 2018 Category: Consumer Health News Source Type: news

Is the Pap Smear On the Way Out?
TUESDAY, July 3, 2018 -- The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests. Its replacement? The human papillomavirus (HPV) test. Nearly all cervical cancer... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 3, 2018 Category: General Medicine Source Type: news

Finding suggest HPV testing detects cervical pre-cancer earlier, more accurately than Pap smear
(JAMA Network) Nearly all cervical cancers are associated with persistent cervical infection from cancer-related human papillomavirus (HPV) strains. Testing for HPV alone, or combined with a Pap smear (cytology) for cervical screening, has been associated with increased detection of precancerous lesions compared with Pap smears alone. Some organizations have recommended primary HPV-based cervical cancer screening, while others have called for clinical trials of primary HPV testing alone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 3, 2018 Category: Cancer & Oncology Source Type: news

Parents Say Cancer Prevention Best Reason for HPV Vaccination
THURSDAY, June 21, 2018 -- Parents view cancer prevention as the best reason for guideline-consistent human papillomavirus (HPV) vaccination, according to a study published online June 14 in Cancer Epidemiology, Biomarkers& Prevention. Melissa... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 21, 2018 Category: Pharmaceuticals Source Type: news

Dr. Adel Mahmoud, Who Was Credited With HPV and Rotavirus Vaccines, Dies at 76
As president of Merck Vaccines, Dr. Mahmoud overcame doubts in developing vaccines against two threats to women and babies: HPV and rotavirus. (Source: NYT Health)
Source: NYT Health - June 19, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Mahmoud, Adel (1941-2018) Human Papillomavirus (HPV) Vaccination and Immunization Deaths (Obituaries) Gardasil (Vaccine) Cervical Cancer Merck & Company Inc Princeton University Rotaviruses Gerberding, Julie L Egypt Source Type: news

Dr. Adel Mahmoud, 76, Dies; Credited With Major Vaccines
As president of Merck Vaccines, Dr. Mahmoud overcome doubts in developing vaccines against two threats to women and babies: HPV and rotavirus. (Source: NYT Health)
Source: NYT Health - June 19, 2018 Category: Consumer Health News Authors: DENISE GRADY Tags: Mahmoud, Adel (1941-2018) Human Papillomavirus (HPV) Vaccination and Immunization Deaths (Obituaries) Gardasil (Vaccine) Cervical Cancer Merck & Company Inc Princeton University Rotaviruses Gerberding, Julie L Egypt Source Type: news

Cancer virus rates fall after vaccinations
THE Human Papillomavirus vaccine programme has led to a fall in the number of young women carrying cancer-causing infections, a study reveals. (Source: Daily Express - Health)
Source: Daily Express - Health - June 18, 2018 Category: Consumer Health News Source Type: news

HPV jabs will be offered to thousands of teen boys on the NHS
UK Health Secretary Jeremy Hunt will give the go-ahead for them to be inoculated against the cancer-causing human papillomavirus, which causes cancer that kills 650 men a year. (Source: the Mail online | Health)
Source: the Mail online | Health - June 18, 2018 Category: Consumer Health News Source Type: news

Parents see cancer prevention potential as best reason for HPV vaccination
(American Association for Cancer Research) Parents of adolescents believed that the potential to prevent certain types of cancer is the best reason for their children to receive the human papillomavirus (HPV) vaccine, whereas other reasons health care providers often give were far less persuasive. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2018 Category: International Medicine & Public Health Source Type: news

Parents ranked cancer prevention as number one provider reason for HPV vaccination
(UNC Lineberger Comprehensive Cancer Center) Parents ranked cancer prevention as the most compelling reason health care providers can give for recommending the human papillomavirus (HPV) vaccine, according to a survey led by University of North Carolina Lineberger Comprehensive Cancer Center researchers. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 14, 2018 Category: Cancer & Oncology Source Type: news

Older Adults Increasingly Have HPV & #43; Oropharyngeal Cancers
WEDNESDAY, June 13, 2018 -- Human papillomavirus (HPV)-positive oropharyngeal cancers are increasing among older adults, according to a study published online April 30 in Cancer. Melina J. Windon, M.D., from Johns Hopkins University in Baltimore,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 13, 2018 Category: Pharmaceuticals Source Type: news

Factors associated with increased risk of suicide among survivors of head and neck cancer: a population-based analysis - Osazuwa-Peters N, Arnold LD, Loux TM, Varvares MA, Schootman M.
OBJECTIVES: Cancer diagnosis is considered an independent predictor of suicide. We aimed to determine whether gender and human papillomavirus (HPV)-relatedness are associated with increased risks of suicide in the head and neck cancer (HNC) population. ... (Source: SafetyLit)
Source: SafetyLit - June 12, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers
THURSDAY, June 7, 2018 -- National Cancer Institute (NCI)-designated cancer centers are endorsing the goal of eliminating cancers caused by the human papillomavirus (HPV) through HPV vaccination and evidence-based cancer screening, according to a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 7, 2018 Category: Pharmaceuticals Source Type: news

MD Anderson and nation's top cancer centers endorse goal of eliminating HPV-related cancers
(University of Texas M. D. Anderson Cancer Center) Recognizing that vaccination rates for the human papillomavirus (HPV) remain low across the U.S., particularly in Texas, The University of Texas MD Anderson Cancer Center again has joined with the 69 other National Cancer Institute (NCI)-designated cancer centers in issuing a joint statement to call for increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the virus. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 7, 2018 Category: Cancer & Oncology Source Type: news

No Link Between HPV Vaccine, Autoimmune Diseases: Study
TUESDAY, May 29, 2018 -- Immunizing girls against human papillomavirus (HPV) doesn't increase their risk for autoimmune diseases, according to new research from Canada. HPV is the world's most common sexually transmitted disease, affecting up to 75... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 29, 2018 Category: General Medicine Source Type: news

No link between HPV vaccination and risk of autoimmune disorders: Study in CMAJ
(Canadian Medical Association Journal) A new study in CMAJ (Canadian Medical Association Journal) found no increased risk of autoimmune disorders in girls who received quadrivalent human papillomavirus (HPV4) vaccination, adding to the body of evidence for the safety of the vaccine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2018 Category: International Medicine & Public Health Source Type: news

Addressing Parents' HPV Vaccine Hesitancy Ups Vaccination Rates
TUESDAY, May 22, 2018 -- Providers engaging parents hesitant about human papillomavirus (HPV) vaccination and addressing their concerns can lead to same-day vaccinations, according to a study published online May 15 in Pediatrics. Laura A. Shay,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 22, 2018 Category: Pharmaceuticals Source Type: news

Increased Rate of ASCUS Diagnosis With HPV Reflex Testing Increased Rate of ASCUS Diagnosis With HPV Reflex Testing
Does concomitantly requested high-risk human papillomavirus reflex testing bias the cytologic interpretation of Pap tests?American Journal of Clinical Pathology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2018 Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news

Good Evidence That HPV Vaccines Protect Against Cervical Precancer
THURSDAY, May 17, 2018 -- Human papillomavirus (HPV) vaccines protect against cervical precancer in adolescent girls and young women, according to a review published online May 9 in the Cochrane Library. Marc Arbyn, M.D., from the Belgian Cancer... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2018 Category: Pharmaceuticals Source Type: news

Cochrane review backs safety of HPV vaccine in wake of claims
Experts who carried out a review of research on the human papillomavirus vaccine have hit out at “unjustified claims” that it can harm women for fear these could prevent them taking up the jab. (Source: Nursing Times)
Source: Nursing Times - May 9, 2018 Category: Nursing Source Type: news

Major review backs cervical cancer shots, especially for teens
(Reuters) - Vaccines designed to prevent infection with human papillomavirus (HPV) are effective in protecting against pre-cancerous cervical lesions in women, particularly in those vaccinated between age 15 and 26, according to a large international evidence review. (Source: Reuters: Health)
Source: Reuters: Health - May 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

HPV vaccines prevent cervical cancer, global review confirms
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Major study confirms HPV vaccines prevent cervical cancer
The human papillomavirus or HPV spreads through intimate contact during sex with someone who is infected. In some women, an HPV infection will persist and lead to cervical cancer. HPV vaccines protect against cervical cancer in young women, especially when the women are vaccinated between the ages of 15 and 26, a new Cochrane Report finds. (Source: CNN.com - Health)
Source: CNN.com - Health - May 8, 2018 Category: Consumer Health News Source Type: news

Scientific expert reaction to new Cochrane Review on HPV vaccine for cervical cancer prevention in girls and women
This study looks at a collection of studies looking at the benefit of HPV vaccines in reducing pre cervical cancer lesions.  HPV also causes many other serious cancers (especially head and neck).  In time, as more people have been vaccinated, we will see a reduction in all HPV cancers.  The HP V vaccine is one of a number of vaccines using virus like particles (VLPS) which have been shown to be very safe over the last 35 years. “The Cochrane library of reviews has a very rigorous assessment process of all their reviews. “The review only looked at cervical precancer (in women and girls),...
Source: Cochrane News and Events - May 8, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news

Does HPV vaccination prevent the development of cervical cancer? Are there harms associated with being vaccinated?
New evidence published today in the Cochrane Library shows that human papilloma virus (HPV) vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26. It also summarizes findings on harms that have been assessed in randomized controlled trials.Most people who have sexual contact at some point in their life will be exposed to the human papilloma virus (HPV). In the majority of women, HPV infection will be cleared by the immune system. When the immune system does not clear the virus, persistent HPV infection can cause abnormal cervical cells. These lesion...
Source: Cochrane News and Events - May 7, 2018 Category: Information Technology Authors: Muriah Umoquit Source Type: news